VAERS Explorer
Back to explore

Report #2861109

Received Sep 24, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
NJ
Recovered
Not recovered
Vaccinated
Aug 21, 2025
Onset
Aug 22, 2025
Days to onset
1
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (NO BRAND NAME)UNKNOWN MANUFACTURER1UNKLA

Symptoms (5)

AstheniaInjection site painMyalgiaPain in extremityParaesthesia

Symptom narrative

her arm hurts from the injection site, all the way down her left arm to her hand; feeling weak; arm pain; left hand is very tingly; muscle pain; This non-serious case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 57-year-old female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On 21-AUG-2025, the patient received the 1st dose of Shingles vaccine (left deltoid). On 22-AUG-2025, 1 days after receiving Shingles vaccine, the patient experienced injection site pain (Verbatim: her arm hurts from the injection site, all the way down her left arm to her hand), feelings of weakness (Verbatim: feeling weak), pain in arm (Verbatim: arm pain), tingling of extremity (Verbatim: left hand is very tingly) and muscle pain (Verbatim: muscle pain). The outcome of the injection site pain, feelings of weakness, pain in arm, tingling of extremity and muscle pain were not resolved. It was unknown if the reporter considered the injection site pain, feelings of weakness, pain in arm, tingling of extremity and muscle pain to be related to Shingles vaccine. It was unknown if the company considered the injection site pain, feelings of weakness, pain in arm, tingling of extremity and muscle pain to be related to Shingles vaccine. Additional Information: GSK receipt date: 03-SEP-2025 The reporter stated that she had received the first dose of the shingles vaccine and experienced feelings of weakness the following day and had needed to take a nap in the afternoon. The patient reported that her left arm had continued to hurt as of day of reporting. She indicated that the pain extended from the injection site down her entire left arm to her hand, and that this had started the day after receiving the vaccine, she noted that the most intense pain was localized at the injection site Additionally, the patient reported experiencing tingling sensations in her left hand and the patient reports that it might be muscle pain. The patient stated that she had received the shingles vaccine at her local pharmacy. All information regarding these adverse events was reported as provided.